Sa1086 Dose Escalation of Vedolizumab From Every 8 Weeks to Every 4 or 6 Weeks Enables Patients With Inflammatory Bowel Disease to Recapture Response
| Autor: | Rory Grace, Frank I. Scott, Antonio Mendoza Ladd, Gary R. Lichtenstein, Hillary Bownik |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Hepatology business.industry Gastroenterology medicine.disease Inflammatory bowel disease Vedolizumab 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Immunology medicine Dose escalation 030211 gastroenterology & hepatology business medicine.drug |
| Zdroj: | Gastroenterology. 150:S235-S236 |
| ISSN: | 0016-5085 |
| DOI: | 10.1016/s0016-5085(16)30859-9 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|